The use of four-factor prothrombin complex concentrate in patients with liver disease on warfarin therapy

被引：2
|
作者：
Stevens, Craig A. [1 ]
Yau, Benny C. [2 ]
Lai, Ngan C. [3 ]
Huang, Wan-Ting [1 ]
Cang, William C. [1 ]
Bushway, Audrey [1 ]
Derry, Katrina L. [1 ]
机构：
[1] UC San Diego Hlth, Dept Pharm, San Diego, CA USA
[2] Stanford Hlth Care, Dept Pharm, Stanford, CA USA
[3] Sutter Hlth Care, Dept Pharm, Oakland, CA USA
来源：
THROMBOSIS RESEARCH | 2021年 / 204卷
关键词：
COAGULOPATHY; PROTECT;
D O I：
10.1016/j.thromres.2021.06.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：123 / 125
页数：3
相关论文
共 50 条
  • [21] Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
    Chapman, Scott A.
    Irwin, Eric D.
    Abou-Karam, Nada M.
    Rupnow, Nichole M.
    Hutson, Katherine E.
    Vespa, Jeffrey
    Roach, Robert M.
    WORLD JOURNAL OF EMERGENCY SURGERY, 2014, 9
  • [22] Coagulation in chronic liver disease and the use of prothrombin complex concentrate for an emergent procedure: a case report and review of literature
    Laubham, Matthew
    Kallwitz, Eric
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2018, 8 (03): : 138 - 141
  • [23] Single-Center Use of Prothrombin Complex Concentrate in Pediatric Patients
    Karube, Takaharu
    Andersen, Courtney
    Tobias, Joseph D.
    JOURNAL OF PEDIATRIC INTENSIVE CARE, 2020, 9 (02) : 106 - 112
  • [24] Four-factor prothrombin complex concentrate to reduce allogenic blood product transfusion in patients with major trauma, the PROCOAG trial: study protocol for a randomized multicenter double-blind superiority study
    Bouzat, Pierre
    Bosson, Jean-Luc
    David, Jean-Stephane
    Riou, Bruno
    Duranteau, Jacques
    Payen, Jean-Francois
    TRIALS, 2021, 22 (01)
  • [25] Outcomes of 4-factor Prothrombin Complex Concentrate in Patients With Liver Disease and Nonvitamin K Antagonist-Related Coagulopathy: A Retrospective Study
    Dodhiawala, Paarth B.
    Pribyl, Kyle
    Larson, Jared
    Vakayil, Victor
    Chandrashekar, Malavika
    Lord, Amanda
    Welbig, Julie
    Zantek, Nicole D.
    Martin, David
    Harmon, James V.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [26] Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retrospective Cohort Study
    Kiskaddon, Amy L.
    Goldenberg, Neil A.
    Fierstein, Jamie L.
    Miller, Alexandra
    Quintessenza, James A.
    Kartha, Vyas M.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024, 50 (06) : 873 - 882
  • [27] Experience on Using Prothrombin Complex Concentrate in Urgent Warfarin Reversal: An Iranian Survey
    Haghpanah, Sezaneh
    Karimi, Mehran
    Bordbar, Mohammadreza
    Kamfiroozi, Rosa
    Asgharzadeh, Hafezeh
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (03) : 277 - 281
  • [28] Prothrombin Complex Concentrate Use in Intracranial Hemorrhage Patients With Cirrhosis Not on Prior Anticoagulation
    Small, Clay
    Attridge, Rebecca L.
    Franco-Martinez, Crystal
    Donnelly, Jonathan
    Barthol, Colleen
    JOURNAL OF INTENSIVE CARE MEDICINE, 2022, 37 (05) : 633 - 640
  • [29] Potential Use of Prothrombin Complex Concentrate in Trauma Resuscitation
    McSwain, Norman, Jr.
    Barbeau, James
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2011, 70 (05): : S53 - S56
  • [30] Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
    Wójcik C.
    Schymik M.L.
    Cure E.G.
    International Journal of Emergency Medicine, 2009, 2 (4) : 217 - 225
12345